<DOC>
	<DOCNO>NCT00004734</DOCNO>
	<brief_summary>A stroke occurs part brain damage lack normal blood supply . This may result difficulty feeling , speech , muscle strength coordination , movement , thinking , brain function . Having stroke increase risk another stroke occur future . Higher blood level natural chemical know homocysteine may contribute harden artery brain heart increase risk stroke heart attack . Folic acid , vitamin B6 ( pyridoxine ) , vitamin B12 ( cyanocobalamin ) may lower blood level homocysteine reduce risk another stroke heart attack .</brief_summary>
	<brief_title>Vitamin Therapy Prevention Stroke</brief_title>
	<detailed_description>The incidence second stroke patient first stroke 7 10 percent per year . Myocardial infarction ( heart attack ) complication stroke add stroke death disability . Because homocysteine may major contributor stroke , reduction appropriate intervention vitamin supplement could reduce impact recurrent stroke , myocardial infarction , vascular death . The purpose trial determine whether multivitamin contain high-dose folic acid , pyridoxine , cyanocobalamin , addition best medical/surgical management risk factor modification , reduce recurrence stroke occurrence myocardial infarction stroke patient elevated homocysteine level .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin B 12</mesh_term>
	<mesh_term>Hydroxocobalamin</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Pyridoxine</mesh_term>
	<mesh_term>Pyridoxal</mesh_term>
	<mesh_term>Vitamin B 6</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<criteria>Any stroke ( nondisabling cerebral infarction , NDCI ) &lt; 120 day prior randomization Symptoms last &gt; 24 hr , &lt; 24 hr , CT MRI show new infarction expect site Modified Rankin score &lt; 3 Homocysteine level &gt; 25th percentile , ie , 9.5 mol/L men , 8.5 mol/L woman Patient compliance multivitamin runin phase &gt; 75 % Stroke due : intracranial hemorrhage , dissection cervicocephalic artery , venoocclusive disease , drug abuse , vasculitis CT MRI show lesion infarction cause syndrome Modified Rankin score 4 5 eligibility Presence potential source cardiogenic embolus : atrial fibrillation , prosthetic cardiac valve , intracardiac thrombus neoplasm , valvular vegetation Neurologic illness stroke would prevent proper evaluation recurrent stroke Illness limit life expectancy &lt; 2 year Severe congestive heart failure Renal insufficiency require dialysis Untreated B12 deficiency untreated pernicious anemia Uncontrolled hypertension ( systolic &gt; 185 mm/Hg diastolic &gt; 105 mm/Hg two reading separate 5 min . ) eligibility Conditions prevent reliable participation study : refractory depression , severe cognitive impairment , alcoholism , substance abuse Medications give within last 30 day affect homocysteine : methotrexate , tamoxifen , Ldopa , phenytoin , bile acid sequestrants decrease folate level Women childbearing potential Patients receive active intervention another trial Patients multivitamin , single B6 , folic acid , unless willing discontinue take study supplement Any surgical procedure , invasive cardiac instrumentation , endarterectomy , stent placement , thrombectomy endovascular treatment abnormal carotid artery perform within 30 day prior randomization schedule within 30 day randomization</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2004</verification_date>
	<keyword>stroke</keyword>
	<keyword>cerebral infarction</keyword>
	<keyword>homocysteine</keyword>
	<keyword>vitamin</keyword>
	<keyword>folic acid</keyword>
	<keyword>pyridoxine</keyword>
	<keyword>vitamin B6</keyword>
	<keyword>cyanocobalamin</keyword>
	<keyword>vitamin B12</keyword>
	<keyword>multivitamin</keyword>
</DOC>